Advertisement

Oncology February 2020 Edition

Atezolizumab + Chemo After Surgery Does Not Improve Survival for Triple-Negative Breast Cancer

Atezolizumab + Chemo After Surgery Does Not Improve Survival for Triple-Negative Breast Cancer

THURSDAY, March 28, 2024 (HealthDay News) -- Patients with triple-negative breast cancer do not benefit from the addition of atezolizumab to their postsurgery chemotherapy treatment, according to a study presented at the annual European Breast Cancer Conference, held...

An ED-Based Smoking Cessation Intervention Is Feasible, Effective

THURSDAY, March 28, 2024 (HealthDay News) -- A brief opportunistic intervention to support sustained tobacco smoking abstinence in the emergency department is feasible and effective, according to a study published online March 26 in the Emergency Medicine...

Rise in Drug-Resistant Gonorrhea in China May Pose Global Threat

THURSDAY, March 28, 2024 (HealthDay News) -- Cases of a strain of highly antibiotic-resistant gonorrhea that first emerged in China in 2016 have tripled there in just five years, according to research published in the March 28 issue of the U.S. Centers for Disease...

Author

Advertisement

For latest news and updates
Email-id is invalid